Search

everythinglearnresearchcommunity

for

Search:↓

Sex hormones may affect COVID-19 severity, with men often faring worse, and targeting related pathways could offer treatment options.

Low-dose oral minoxidil helps hair regrowth in COVID-19-related hair loss with few side effects.

Grey hair and baldness may be linked to COVID-19 severity, but more analysis is needed; post-infectious hair loss is related to the severity of the disease and usually recovers within 3-6 months.

Teledermatology became a valuable and convenient tool for skin care during the COVID-19 pandemic.

Some COVID-19 patients have skin issues, with men, ICU patients, and those on multiple antibiotics at higher death risk; in-person skin checks by dermatologists are more effective.

COVID-19 can lead to different skin symptoms and might trigger autoimmune diseases in genetically susceptible people.

COVID-19 has increased hair loss, but many patients see regrowth within months.

Most skin issues were due to COVID-19, with some caused by vaccines or treatments, and were categorized into five types.

Social media data can help track COVID-19 symptoms and predict the pandemic's status.

Social media data can help track and predict COVID-19 symptoms and trends.

Long COVID-19 patients with skin pain might have a nerve condition that responds to a medication called gabapentin.

Early treatment with certain drug combinations improved COVID-19 outcomes and prevented severe disease in males, including those at higher risk.

Men with androgenetic alopecia and hypertension may experience more severe COVID-19.

Men on 5-alpha-reductase inhibitors might have worse COVID-19 outcomes.

Anti-androgen therapy might help protect against COVID-19 infection and reduce death risk.

Women with conditions like PCOS may have a higher risk of COVID-19, but treatments like isotretinoin could help those with acne.

Women with PCOS are more vulnerable to severe COVID-19 and related health issues.

Skin problems like rashes and hair loss can help diagnose and predict COVID-19.

COVID-19 and its vaccines can cause hair loss, which is not serious and can improve with psychological support.

PrEP doesn't increase STI risk in high-risk men, anti-androgen drugs may lower ICU admission for male COVID-19 patients, a 3-point injection is better for crow's feet, and the 'Geriatric-8' tool could help assess frailty in older skin cancer patients.

The document highlights advancements and findings in dermatology, including AI use, disease prevention, treatment efficacy, and the impact of conditions on patients' lives.

COVID-19 may cause hair loss and scalp pain due to inflammation and changes in hair follicle receptors, but these symptoms typically resolve in 2 to 4 months.

The conclusion is that individual differences in COVID-19 severity are influenced by factors like age, sex, race, and genetics, which are important for personalized medicine.

COVID-19 can cause skin issues like chilblains and rashes, which may help in early detection, especially in patients without other symptoms.

Non-Kuwaiti COVID-19 patients had worse health outcomes than Kuwaitis, likely due to poorer socioeconomic conditions.

COVID-19 patients often have skin issues like chilblain-like lesions and rashes, which can help in early diagnosis and sometimes indicate severe illness.

COVID-19 may affect male fertility and women might have better outcomes due to hormonal and immune differences.

Higher dihydrotestosterone may be linked to more inflammation in COVID-19 patients with low testosterone.

COVID-19 can cause various skin issues, including rashes and lesions.

The COVID-19 pandemic led to fewer skin checks and skin cancer diagnoses in Australia in 2020.